A new tourniquet for intravenous regional anesthesia.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Hartley.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
SDZ 216,525 has been proposed to be a silent 5-HT1A receptor antagonist. The present study examined the potential intrinsic agonist action of SDZ 216,525 using two in vivo models of somatodendritic 5-HT1A autoreceptor function: 5-HT release using microdialysis and feeding behaviour of satiated animals. SDZ 216,525 (1 mg/kg s.c.) and the alpha 1-adrenoceptor antagonist prazosin (1 mg/kg s.c.) significantly decreased hippocampal 5-HT release. In addition, SDZ 216,525 (3 and 10 mg/kg s.c.) and prazosin (3 and 10 mg/kg s.c.) significantly increased food intake in satiated rats. The selective 5-HT1A receptor antagonist (RS)-WAY100135 (10 mg/kg s.c.) which has been demonstrated to block the effects of 8-OH-DPAT on 5-HT release and food intake had no significant effect on the response induced by SDZ 216,525. In contrast, the non-selective 5-HT1A receptor antagonist (-)-pindolol (8 mg/kg s.c.) attenuated both SDZ 216,525 responses. The decrease in hippocampal 5-HT release and increase in food intake induced by SDZ 216,525 suggest that the compound may be a 5-HT1A receptor partial agonist. However, the failure of the 5-HT1A receptor antagonist (RS)-WAY100135 to block the SDZ 216,525 responses suggests that SDZ 216,525 decreases 5-HT release and increases food intake by a mechanism other than 5-HT1A receptor agonism. The high affinity of SDZ 216,525 for the alpha 1-adrenoceptor, and the ability of prazosin to decrease 5-HT release and increase food intake, suggest that the effects of SDZ 216,525 may be mediated via an alpha 1-adrenoceptor antagonist action.
Lung cancer deaths occurring between 1935 and 1969 among women residing near an arsenic emitting smelter were examined. For three geographically defined exposure groups, the observed and expected number of lung cancer deaths were compared. In none of the exposure groups did the observed number of deaths exceed the expected. However, an index of exposure based on distance of residence from the smelter and duration of residence in the area was 27% higher for cases than for age-matched controls (p = .10). Adjusting for a latency of 20 yr, case exposures were 23% higher than for controls (p = .07). Dividing individuals into quintiles of exposure yielded odds ratios ranging from 1 to 1.6 (test of trend, p = .07).
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.